S-acyl-2-thioethyl aryl phosphotriester derivatives of AZT: synthesis, antiviral activity, and stability study. 2003

Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
UMR 5625 CNRS-UMII, Université Montpellier II, Case Courrier 008, Place Eugène Bataillon, 34095 Montpellier Cedex 05, France.

The synthesis, antiviral activity, and stability study of phosphotriester derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) bearing modified l-tyrosinyl residues are reported. These compounds were obtained via phosphoramidite (P(III)) chemistry from the appropriate aryl precursors. All the derivatives were evaluated for their in vitro anti-HIV activity, and they appeared to be potent inhibitors of HIV-1 replication in various cell culture experiments, with EC(50) values between the micro- and nanomolar range, especially in thymidine kinase deficient (TK(-)) cells, showing their ability to act as mononucleotide prodrugs. The proposed decomposition process of these mixed mononucleoside aryl phosphotriesters successively involves an esterase and a phosphodiesterase hydrolysis.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010755 Organophosphates Carbon-containing phosphoric acid derivatives. Included under this heading are compounds that have CARBON atoms bound to one or more OXYGEN atoms of the P( Organophosphate,Phosphates, Organic,Phosphoric Acid Esters,Organopyrophosphates,Acid Esters, Phosphoric,Esters, Phosphoric Acid,Organic Phosphates
D002457 Cell Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Cell Extract,Extract, Cell,Extracts, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D013440 Sulfides Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. Sulfide,Thioether,Thioethers,Sulfur Ethers,Ethers, Sulfur
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
November 2000, Journal of medicinal chemistry,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
January 1999, Antiviral research,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
June 1991, Journal of medicinal chemistry,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
October 2003, Journal of medicinal chemistry,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
September 1995, Journal of medicinal chemistry,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
January 1999, Nucleosides & nucleotides,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
December 1996, Journal of medicinal chemistry,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
January 2000, Nucleosides, nucleotides & nucleic acids,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
June 2008, ChemMedChem,
Suzanne Peyrottes, and Gaëlle Coussot, and Isabelle Lefebvre, and Jean-Louis Imbach, and Gilles Gosselin, and Anne-Marie Aubertin, and Christian Périgaud
July 2020, Bioorganic chemistry,
Copied contents to your clipboard!